bluebird bio Inc. (BLUE)
NASDAQ: BLUE
· Real-Time Price · USD
4.97
0.00 (0.00%)
At close: May 30, 2025, 3:59 PM
bluebird bio Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|
| Other Revenue Revenue | 858K | 812K |
| Other Revenue Revenue Growth | +5.67% | n/a |
| Product Revenue | 2.74M | 2.85M |
| Product Revenue Growth | -3.89% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 30.26M | 31.39M | 39.77M | 50.38M | 46.33M | 47.1M | 40.7M | 40.35M | 37.35M | 30.71M | 33.4M | 36.69M | 36.11M | 53.21M | 68.28M | 78.58M | 86.87M | 76.97M | 68.05M | 68.63M | 73.25M | 76.2M | 66.25M | 68.63M | 60.28M | 53.51M | 44.53M | 41.17M | 34.93M | 29.09M | 22.98M | 21.2M | 20.28M | 16.18M | 14.62M | 18.36M | 15.96M | 14.44M | 13.7M | 10.72M | 7.34M |
| Selling, General, and Administrative Revenue Growth | -3.61% | -21.05% | -21.08% | +8.75% | -1.65% | +15.73% | +0.88% | +8.02% | +21.65% | -8.07% | -8.97% | +1.63% | -32.14% | -22.07% | -13.11% | -9.55% | +12.86% | +13.12% | -0.85% | -6.31% | -3.88% | +15.02% | -3.47% | +13.86% | +12.65% | +20.17% | +8.16% | +17.87% | +20.07% | +26.56% | +8.42% | +4.50% | +25.38% | +10.63% | -20.37% | +15.09% | +10.46% | +5.40% | +27.79% | +46.18% | n/a |
| Research and Development Revenue | 17.72M | 20.84M | 23.17M | 25.16M | 25.07M | 33.77M | 45.46M | 42.27M | 46.14M | 45.9M | 53.15M | 63.84M | 77.88M | 79.38M | 131.43M | 144.31M | 154.48M | 137.09M | 140.43M | 156.31M | 154.12M | 161.82M | 151.41M | 146.54M | 122.64M | 119.72M | 116.74M | 115.01M | 97.11M | 92.58M | 61.55M | 64.31M | 55.03M | 57.13M | 63.97M | 41.76M | 41.91M | 35.66M | 30.39M | 44.27M | 23.72M |
| Research and Development Revenue Growth | -14.98% | -10.05% | -7.90% | +0.36% | -25.76% | -25.72% | +7.54% | -8.39% | +0.53% | -13.64% | -16.75% | -18.02% | -1.90% | -39.60% | -8.93% | -6.58% | +12.68% | -2.38% | -10.16% | +1.42% | -4.76% | +6.87% | +3.32% | +19.49% | +2.44% | +2.55% | +1.50% | +18.44% | +4.90% | +50.42% | -4.30% | +16.87% | -3.68% | -10.69% | +53.19% | -0.36% | +17.53% | +17.32% | -31.34% | +86.63% | n/a |